PROLUMINAR

LIVE

Serial Number

79417269

Owner

Telix Pharmaceuticals Limited

Attorney

Andrew S. Ehard

Filing Date

Sep 20, 2024

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

PROLUMINAR Trademark

Serial Number: 79417269 • Registration: 8112860

PROLUMINAR is a trademark filed by Telix Pharmaceuticals Limited on September 20, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 10 - Medical Apparatus

Surgical, medical, dental and veterinary apparatus and instruments

Owner Contact Info

Telix Pharmaceuticals Limited (38 trademarks)

Suite 401, 55 Flemington Road

Entity Type: 99

Legal Representation

Attorney of Record

Andrew S. Ehard

5,525 trademarks filed View all →

Correspondence Address

Andrew S. Ehard Merchant & Gould, P.C.

P.O. Box 2910

Minneapolis, MN 55402

United States

Trademark Details

Filing Date

September 20, 2024

Registration Date

January 27, 2026

Published for Opposition

December 9, 2025

Goods & Services

Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices sold empty, namely, syringes and infusion sets for diagnostic radiopharmaceuticals; medical devices for treating cancer; radiopharmaceutical diagnostic imaging apparatus for medical use

Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing and monitoring of cancer

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Apr 27, 2026 FICR

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jan 27, 2026 NRCC

REGISTERED-PRINCIPAL REGISTER

Jan 27, 2026 R.PR

NEW REPRESENTATIVE AT IB RECEIVED

Jan 22, 2026 NREP

NEW REPRESENTATIVE AT IB RECEIVED

Jan 1, 2026 NREP

NOTIFICATION PROCESSED BY IB

Dec 11, 2025 GPNX

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 9, 2025 NPUB

PUBLISHED FOR OPPOSITION

Dec 9, 2025 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 3, 2025 NONP

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Nov 26, 2025 OPNS

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Nov 25, 2025 OP2R

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 13, 2025 CNSA

EXAMINER'S AMENDMENT ENTERED

Nov 13, 2025 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Nov 13, 2025 GNEN

EXAMINERS AMENDMENT E-MAILED

Nov 13, 2025 GNEA

EXAMINERS AMENDMENT -WRITTEN

Nov 13, 2025 CNEA

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 10, 2025 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 10, 2025 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 10, 2025 TROA

REFUSAL PROCESSED BY IB

May 31, 2025 RFNT

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

May 9, 2025 RFCS

REFUSAL PROCESSED BY MPU

May 9, 2025 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Mar 21, 2025 RFCR

NON-FINAL ACTION WRITTEN

Mar 20, 2025 CNRT

ASSIGNED TO EXAMINER

Mar 20, 2025 DOCK

APPLICATION FILING RECEIPT MAILED

Mar 19, 2025 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 19, 2025 NWOS

LIMITATION FROM ORIGINAL APPLICATION ENTERED

Mar 17, 2025 LIMI

SN ASSIGNED FOR SECT 66A APPL FROM IB

Feb 20, 2025 REPR

Related Trademarks

More from this Owner

LUTEON

PTHER-PAN

BIPASS

UROONCRX ONSITE PRECISION RADIOPHARMACY

More in Same Class

PINEMED

JOISPARK